The Scientific Advisors team at WindMIL Therapeutics plays a critical role in guiding the research and development of innovative oncology cell therapies. This team comprises experts who provide strategic insights, evaluate scientific data, and collaborate with cross-functional groups to advance the understanding and clinical application of MILs™ (Marrow Infiltrating Lymphocytes), ensuring the company remains at the forefront of therapeutic advancements in oncology.
View all